Acknowledgement
Supported by : National Research Foundation of Korea (NRF)
References
- Vermeire S, van Assche G, Rutgeerts P. Review article: altering the natural history of Crohn's disease: evidence for and against current therapies. Aliment Pharmacol Ther 2007;25:3-12. https://doi.org/10.1111/j.1746-6342.2006.03215.x
- Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001;7:306-313. https://doi.org/10.1097/00054725-200111000-00005
- Sands BE, Ooi CJ. A survey of methodological variation in the Crohn's disease activity index. Inflamm Bowel Dis 2005;11:133-138. https://doi.org/10.1097/00054725-200502000-00006
- Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support. Diabetes Care 2013;36 Suppl 1:S100-S108. https://doi.org/10.2337/dc13-S100
- Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322-334. https://doi.org/10.1016/S0140-6736(11)61294-4
- Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut 2010;59:1652-1661. https://doi.org/10.1136/gut.2010.220160
- Van Deen WK, van der Meulen-de Jong AE, Parekh NK, et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol 2016;14:1742-1750. https://doi.org/10.1016/j.cgh.2015.10.035
- Kim ES, Park KS, Cho KB, et al. Development of a webbased, self-reporting symptom diary for Crohn's disease, and its correlation with the Crohn's Disease Activity Index: web-based, self-reporting symptom diary for Crohn's Disease. J Crohns Colitis 2017;11:1449-1455.
- Jensen RE, Rothrock NE, DeWitt EM, et al. The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care 2015;53:153-159. https://doi.org/10.1097/MLR.0000000000000289
- Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 2014;12:1246-1256. https://doi.org/10.1016/j.cgh.2014.02.016
- Ramos-Rivers C, Regueiro M, Vargas EJ, et al. Association between telephone activity and features of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014;12:986-994. https://doi.org/10.1016/j.cgh.2013.11.015
- Sulz MC, Siebert U, Arvandi M, et al. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol 2013;25:790-797. https://doi.org/10.1097/MEG.0b013e32836019b9
- Nguyen GC, Sheng L, Benchimol EI. Health care utilization in elderly onset inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2015;21:777-782. https://doi.org/10.1097/MIB.0000000000000306
- Gajendran M, Umapathy C, Loganathan P, Hashash JG, Koutroubakis IE, Binion DG. Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA. Dig Dis Sci 2016;61:389-399. https://doi.org/10.1007/s10620-015-3895-2
- Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis 2015;21:392-399. https://doi.org/10.1097/MIB.0000000000000241
- Cross RK, Cheevers N, Rustgi A, Langenberg P, Finkelstein J. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis 2012;18:1018-1025. https://doi.org/10.1002/ibd.21795
- Cross RK, Jambaulikar G, Langenberg P, et al. Telemedicine for patients with inflammatory bowel disease (TELEIBD): design and implementation of randomized clinical trial. Contemp Clin Trials 2015;42:132-144. https://doi.org/10.1016/j.cct.2015.03.006
- Lazarev M, Huang C, Bitton A, et al. Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol 2013;108:106-112. https://doi.org/10.1038/ajg.2012.389
- Gathungu G, Kim MO, Ferguson JP, et al. Granulocytemacrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis 2013;19:1671-1680. https://doi.org/10.1097/MIB.0b013e318281f506
Cited by
- Clinical usefulness of remote patient monitoring using e-Health technologies in patients with inflammatory bowel diseases vol.33, pp.5, 2018, https://doi.org/10.3904/kjim.2018.298